Asset Allocation

As of March 31, 2026.
Type % Net
Cash 1.57%
Stock 42.66%
Bond 54.30%
Convertible 0.02%
Preferred 0.00%
Other 1.45%
View Asset Allocation
Start Trial

Market Capitalization

As of March 31, 2026
Large 75.45%
Mid 14.51%
Small 10.05%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 88.41%    % Emerging Markets: 3.20%    % Unidentified Markets: 8.39%

Americas 80.85%
77.68%
Canada 1.58%
United States 76.10%
3.17%
Brazil 1.41%
Chile 0.43%
Mexico 0.30%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 7.48%
United Kingdom 1.81%
5.67%
France 1.83%
Germany 0.77%
Ireland 1.13%
Netherlands 0.68%
Sweden 0.15%
0.00%
0.00%
Greater Asia 3.28%
Japan 0.71%
0.63%
Australia 0.63%
1.57%
Taiwan 1.57%
0.37%
China 0.37%
Unidentified Region 8.39%

Bond Credit Quality Exposure

AAA 9.59%
AA 42.56%
A 13.89%
BBB 15.79%
BB 0.22%
B 0.00%
Below B 1.04%
    CCC 0.00%
    CC 0.00%
    C 1.04%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.34%
Not Available 16.57%
Short Term 0.00%
As of March 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
35.86%
Materials
5.48%
Consumer Discretionary
11.53%
Financials
15.54%
Real Estate
3.31%
Sensitive
46.34%
Communication Services
8.93%
Energy
0.00%
Industrials
11.06%
Information Technology
26.35%
Defensive
10.55%
Consumer Staples
0.00%
Health Care
9.68%
Utilities
0.87%
Not Classified
7.25%
Non Classified Equity
0.00%
Not Classified - Non Equity
7.25%
As of March 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of March 31, 2026
Type % Net
Government 39.26%
Corporate 25.45%
Securitized 33.64%
Municipal 1.30%
Other 0.34%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
4.60%
Less than 1 Year
4.60%
Intermediate
39.31%
1 to 3 Years
4.99%
3 to 5 Years
8.27%
5 to 10 Years
26.05%
Long Term
55.75%
10 to 20 Years
19.82%
20 to 30 Years
31.19%
Over 30 Years
4.74%
Other
0.34%
As of March 31, 2026
View Bond Maturity Exposure
Start Trial